after all the boasting and pumping and not buying one share of his own company, looks like the street is catching on. I sold in the last pump and dump up to 6.00. Just came back to see if it was the right move. SICKENING for the new investors in ARRY
Can Zytiga and Provenge be Used as Combination Therapy for Prostate Cancer? The presence of two relatively new treatments for metastatic prostate cancer--Zytiga (abiraterone) and Provenge (sipuleucel-T)--both of which have been shown to extend overall survival, has led some men to ask whether it is possible for them to be treated with both therapies. After all, combination treatment is common in the treatment of most cancers, including prostate cancer, and so taking both Zytiga and Provenge appears to be a possibility, especially since they work in different ways in the body.
But could it be that the differences between Zytiga and Provenge may be what prevents men from being treated with both therapies? First, some basic facts about each of these treatment options for advanced prostate cancer will help answer this question.
SEC should be pounding their doot